T cell receptor-Vα analysis identifies a dominant CD60+ CD26- CD49d- T cell clone in the peripheral blood of Sézary syndrome patients [4]

Journal of Investigative Dermatology

Volumn 119, Issue 1, 2002, Pages 193-196

  Scala, Enrico ^a   Narducci, Maria Grazia ^a   Amerio, Paolo ^a   Baliva, Giannandrea ^a   Simoni, Romeo ^a   Giovannetti, Antonello ^b   Silvestri, Lorena ^a   Puddu, Pietro ^a   De Pita, Ornella ^a   Russo, Giandomenico ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA4 INTEGRIN; BETA1 INTEGRIN; COLLAGEN; DIPEPTIDYL PEPTIDASE IV; FIBRONECTIN; MONOCLONAL ANTIBODY; RNA; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR VBETA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

CELL MIGRATION; CLINICAL FEATURE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOPHENOTYPING; LETTER; LYMPHOCYTE CLONE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PUVA; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEZARY SYNDROME; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 18644382456     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.18194.x     Document Type: Letter

References (14)

1. Bagot M, Echchakir H, Mami-Chouaib F, et al: Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood 91:4331-4341, 1998
2. Bernengo MG, Novelli M, Quaglino P, et al: The relevance of the CD4+ CD26-subset in the identification of circulating Sézary cells. Br J Dermatol 144:125-135, 2001
3. Bigler RD, Boselli CM, Foley B, Vonderheid EC: Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndrome. Am J Pathol 149:1477-1483, 1996
4. Dummer R, Nestle FO, Niederer E, et al: Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome. Arch Dermatol Res 291:307-311, 1999
5. Folch G, Scaviner D, Contet V, Lefranc MP: Protein displays of the human T cell receptor alpha, beta, gamma and delta variable and joining regions. Exp Clin Immunogenet 17:205-215, 2000
6. Gorochov G, Bachelez H, Cayuela JM, Legac E, Laroche L, Dubertret L, Sigaux F: Expression of V beta gene segments by Sézary cells. J Invest Dermatol 105:56-61, 1995
7. Hansen ER, Vejlsgaard GL, Cooper KD, et al: Leukemic T cells from patients with cutaneous T-cell lymphoma demonstrate enhanced activation through CDw60, CD2, and CD28 relative to activation through the T-cell antigen receptor complex. J Invest Dermatol 100:667-673, 1993
8. Harwix S, Gunzl HJ, Blaschke V, Zachmann K, Neumann C: Inability to culture the dominant T-cell clone from the skin of primary cutaneous T-cell lymphoma as proven by TCR gamma-chain gene sequencing. Arch Dermatol Res 293:139-146, 2001
9. Jones D, Dang NH, Duvic M, Washington LT, Huh YO: Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 115:885-892, 2001
10. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C: Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261:466-469, 1993
11. Langerak AW, van Den Beemd R, Wolvers-Tettero IL, Boor PP, van Lochem EG, Hooijkaas H, van Dongen JJ: Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood 98:165-173, 2001
12. Masuyama J, Berman JS, Cruikshank WW, Morimoto C, Center DM: Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J Immunol 148:1367-1374, 1992
13. McCusker ME, Garifallou M, Bogen SA: Sézary lineage cells can be induced to proliferate via CD28-mediated costimulation. J Immunol 158:4984-4991, 1997
14. Rappl G, Muche JM, Abken H, Sterry W, Tilgen W, Ugurel S, Reinhold U: CD4(+) CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome. J Am Acad Dermatol 44:456-461, 2001